Hervé Schaffhauser

2.4k total citations
45 papers, 2.0k citations indexed

About

Hervé Schaffhauser is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Hervé Schaffhauser has authored 45 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 32 papers in Cellular and Molecular Neuroscience and 6 papers in Organic Chemistry. Recurrent topics in Hervé Schaffhauser's work include Neuroscience and Neuropharmacology Research (31 papers), Receptor Mechanisms and Signaling (23 papers) and Ion channel regulation and function (12 papers). Hervé Schaffhauser is often cited by papers focused on Neuroscience and Neuropharmacology Research (31 papers), Receptor Mechanisms and Signaling (23 papers) and Ion channel regulation and function (12 papers). Hervé Schaffhauser collaborates with scholars based in United States, Switzerland and United Kingdom. Hervé Schaffhauser's co-authors include P. Jeffrey Conn, Michael J. Marino, Blake A. Rowe, Thomas A. Macek, Una C. Campbell, Lorrie P. Daggett, Laura E. Chavez-Noriega, Jean‐Michel Vernier, Vincent Mutel and Linda J. Bristow and has published in prestigious journals such as Journal of Neuroscience, The Journal of Comparative Neurology and Scientific Reports.

In The Last Decade

Hervé Schaffhauser

44 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hervé Schaffhauser United States	28	1.5k	1.3k	256	154	154	45	2.0k
Sara Rao United States	15	1.6k 1.0×	1.1k 0.8×	250 1.0×	66 0.4×	134 0.9×	18	2.1k
Stephan Urwyler Switzerland	25	2.2k 1.4×	1.7k 1.3×	252 1.0×	142 0.9×	182 1.2×	55	2.8k
Aida Sacaan United States	24	1.8k 1.2×	1.6k 1.2×	281 1.1×	190 1.2×	123 0.8×	52	2.5k
Juan F. López‐Giménez United Kingdom	24	2.0k 1.3×	1.6k 1.2×	212 0.8×	180 1.2×	186 1.2×	39	2.7k
Michael P. Johnson United States	25	1.8k 1.2×	1.1k 0.8×	228 0.9×	364 2.4×	164 1.1×	52	2.6k
John L. Musachio United States	31	1.2k 0.8×	1.8k 1.3×	152 0.6×	359 2.3×	259 1.7×	80	3.0k
Gemma Molinaro Italy	30	1.2k 0.8×	1.1k 0.8×	312 1.2×	211 1.4×	118 0.8×	58	2.5k
Robert R. Luedtke United States	31	1.9k 1.2×	2.1k 1.5×	134 0.5×	128 0.8×	231 1.5×	99	2.9k
C. Guérémy France	25	1.7k 1.1×	1.3k 0.9×	265 1.0×	160 1.0×	342 2.2×	51	2.6k
Jeffrey F. DiBerto United States	19	1.2k 0.8×	1.2k 0.9×	270 1.1×	87 0.6×	176 1.1×	31	2.0k

Countries citing papers authored by Hervé Schaffhauser

Since Specialization

Citations

This map shows the geographic impact of Hervé Schaffhauser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hervé Schaffhauser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hervé Schaffhauser more than expected).

Fields of papers citing papers by Hervé Schaffhauser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hervé Schaffhauser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hervé Schaffhauser. The network helps show where Hervé Schaffhauser may publish in the future.

Co-authorship network of co-authors of Hervé Schaffhauser

This figure shows the co-authorship network connecting the top 25 collaborators of Hervé Schaffhauser. A scholar is included among the top collaborators of Hervé Schaffhauser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hervé Schaffhauser. Hervé Schaffhauser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vignon, Christine, et al.. (2025). Validation of a potency assay for CD34 + cell based therapy. Scientific Reports. 15(1). 29409–29409.

Rudolph, M.G., Jason C. Cole, Michael Reutlinger, et al.. (2022). A high quality, industrial data set for binding affinity prediction: performance comparison in different early drug discovery scenarios. Journal of Computer-Aided Molecular Design. 36(10). 753–765. 25 indexed citations

Raddatz, Rita, Robert L. Hudkins, Joanne R. Mathiasen, et al.. (2011). CEP-26401 (Irdabisant), a Potent and Selective Histamine H3 Receptor Antagonist/Inverse Agonist with Cognition-Enhancing and Wake-Promoting Activities. Journal of Pharmacology and Experimental Therapeutics. 340(1). 124–133. 52 indexed citations

Schaffhauser, Hervé, Joanne R. Mathiasen, Amy DiCamillo, et al.. (2009). Dimebolin is a 5-HT6 antagonist with acute cognition enhancing activities. Biochemical Pharmacology. 78(8). 1035–1042. 53 indexed citations

West, Peter J., Val R. Marcy, Michael J. Marino, & Hervé Schaffhauser. (2009). Activation of the 5-HT6 receptor attenuates long-term potentiation and facilitates GABAergic neurotransmission in rat hippocampus. Neuroscience. 164(2). 692–701. 82 indexed citations

Rowe, Blake A., Hervé Schaffhauser, Laura S. Lubbers, et al.. (2008). Transposition of Three Amino Acids Transforms the Human Metabotropic Glutamate Receptor (mGluR)-3-Positive Allosteric Modulation Site to mGluR2, and Additional Characterization of the mGluR2-Positive Allosteric Modulation Site. Journal of Pharmacology and Experimental Therapeutics. 326(1). 240–251. 38 indexed citations

Wisnoski, David D., Julie A. O’Brien, Wei Lemaire, et al.. (2006). Challenges in the development of mGluR5 positive allosteric modulators: The discovery of CPPHA. Bioorganic & Medicinal Chemistry Letters. 17(5). 1386–1391. 58 indexed citations

O’Brien, Julie A., Wei Lemaire, Marion Wittmann, et al.. (2004). A Novel Selective Allosteric Modulator Potentiates the Activity of Native Metabotropic Glutamate Receptor Subtype 5 in Rat Forebrain. Journal of Pharmacology and Experimental Therapeutics. 309(2). 568–577. 132 indexed citations

Pinkerton, Anthony B., Rowena V. Cube, John H. Hutchinson, et al.. (2004). Allosteric potentiators of the metabotropic glutamate receptor 2 (mGlu2). Part 1: Identification and synthesis of phenyl-tetrazolyl acetophenones. Bioorganic & Medicinal Chemistry Letters. 14(21). 5329–5332. 23 indexed citations

10.

Stearns, Brian A., Brian T. Campbell, Chixu Chen, et al.. (2004). Synthesis and biological evaluation of 6-aryl-6 H -pyrrolo[3,4- d ]pyridazine derivatives: high-affinity ligands to the α 2 δ subunit of voltage gated calcium channels. Bioorganic & Medicinal Chemistry Letters. 14(5). 1295–1298. 14 indexed citations

11.

Lim, Jongwon, Nicholas Stock, Richard Pracitto, et al.. (2004). N-Acridin-9-yl-butane-1,4-diamine derivatives: high-affinity ligands of the α2δ subunit of voltage gated calcium channels. Bioorganic & Medicinal Chemistry Letters. 14(8). 1913–1916. 10 indexed citations

12.

Lebsack, Alec D., Janet L. Gunzner, Bowei Wang, et al.. (2004). Identification and synthesis of [1,2,4]triazolo[3,4-a]phthalazine derivatives as high-affinity ligands to the α2δ-1 subunit of voltage gated calcium channel. Bioorganic & Medicinal Chemistry Letters. 14(10). 2463–2467. 29 indexed citations

13.

O’Brien, Julie A., Wei Lemaire, Tsing‐Bau Chen, et al.. (2003). A Family of Highly Selective Allosteric Modulators of the Metabotropic Glutamate Receptor Subtype 5. Molecular Pharmacology. 64(3). 731–740. 170 indexed citations

14.

Lorrain, Daniel S., Hervé Schaffhauser, Una C. Campbell, et al.. (2003). Group II mGlu Receptor Activation Suppresses Norepinephrine Release in the Ventral Hippocampus and Locomotor Responses to Acute Ketamine Challenge. Neuropsychopharmacology. 28(9). 1622–1632. 78 indexed citations

15.

Schaffhauser, Hervé, Blake A. Rowe, Laura E. Chavez-Noriega, et al.. (2003). Pharmacological Characterization and Identification of Amino Acids Involved in the Positive Modulation of Metabotropic Glutamate Receptor Subtype 2. Molecular Pharmacology. 64(4). 798–810. 137 indexed citations

16.

Chavez-Noriega, Laura E., Hervé Schaffhauser, & Una C. Campbell. (2002). Metabotropic Glutamate Receptors: Potential Drug Targets for the Treatment of Schizophrenia. PubMed. 1(3). 261–281. 74 indexed citations

17.

Cai, Zhaohui, Julie A. Saugstad, Scott D. Sorensen, et al.. (2001). Cyclic AMP‐dependent protein kinase phosphorylates group III metabotropic glutamate receptors and inhibits their function as presynaptic receptors. Journal of Neurochemistry. 78(4). 756–766. 50 indexed citations

18.

Schaffhauser, Hervé, Frédéric Knoflach, Zaiga Bleuel, et al.. (1998). Multiple pathways for regulation of the KCl-induced [3H]-GABA release by metabotropic glutamate receptors, in primary rat cortical cultures. Brain Research. 782(1-2). 91–104. 35 indexed citations

19.

Cartmell, Jayne, Hervé Schaffhauser, Jürgen Wichmann, & Vincent Mutel. (1997). mGluR‐evoked augmentation of receptor‐mediated cyclic AMP formation in neonatal and adult rat striatum. British Journal of Pharmacology. 121(7). 1263–1268. 10 indexed citations

20.

Schaffhauser, Hervé, et al.. (1997). Involvement of a cyclic-AMP pathway in group I metabotropic glutamate receptor responses in neonatal rat cortex. European Journal of Pharmacology. 334(2-3). 289–297. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact